These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
471 related articles for article (PubMed ID: 32954998)
1. The Emergence of Human Pathogenic Coronaviruses: Lectins as Antivirals for SARS-CoV-2. Sohrab SS; Suhail M; Kamal MA; Ahmad F; Azhar EI Curr Pharm Des; 2020; 26(41):5286-5292. PubMed ID: 32954998 [TBL] [Abstract][Full Text] [Related]
2. Emergence and Re-emergence of Human Coronaviruses: Spike Protein as the Potential Molecular Switch and Pharmaceutical Target. Ahmad F; Kamal MA; Tekwani BL Curr Pharm Des; 2021; 27(33):3566-3576. PubMed ID: 33327904 [TBL] [Abstract][Full Text] [Related]
3. Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses. Artese A; Svicher V; Costa G; Salpini R; Di Maio VC; Alkhatib M; Ambrosio FA; Santoro MM; Assaraf YG; Alcaro S; Ceccherini-Silberstein F Drug Resist Updat; 2020 Dec; 53():100721. PubMed ID: 33132205 [TBL] [Abstract][Full Text] [Related]
4. [Source of the COVID-19 pandemic: ecology and genetics of coronaviruses (Betacoronavirus: Coronaviridae) SARS-CoV, SARS-CoV-2 (subgenus Sarbecovirus), and MERS-CoV (subgenus Merbecovirus).]. Lvov DK; Alkhovsky SV Vopr Virusol; 2020; 65(2):62-70. PubMed ID: 32515561 [TBL] [Abstract][Full Text] [Related]
5. Abelson Kinase Inhibitors Are Potent Inhibitors of Severe Acute Respiratory Syndrome Coronavirus and Middle East Respiratory Syndrome Coronavirus Fusion. Coleman CM; Sisk JM; Mingo RM; Nelson EA; White JM; Frieman MB J Virol; 2016 Oct; 90(19):8924-33. PubMed ID: 27466418 [TBL] [Abstract][Full Text] [Related]
6. Properties of Coronavirus and SARS-CoV-2. Malik YA Malays J Pathol; 2020 Apr; 42(1):3-11. PubMed ID: 32342926 [TBL] [Abstract][Full Text] [Related]
7. SARS-CoV-2: An Update on Potential Antivirals in Light of SARS-CoV Antiviral Drug Discoveries. Elshabrawy HA Vaccines (Basel); 2020 Jun; 8(2):. PubMed ID: 32585913 [TBL] [Abstract][Full Text] [Related]
8. Nucleoside Inhibitors of Coronaviruses. Zenchenko AA; Drenichev MS; Mikhailov SN Curr Med Chem; 2021; 28(26):5284-5310. PubMed ID: 33563148 [TBL] [Abstract][Full Text] [Related]
9. Coronaviruses - a new old menace. Golke A; Piekarska K; Dzieciątkowski T Postepy Biochem; 2020 Dec; 66(4):303-308. PubMed ID: 33470077 [TBL] [Abstract][Full Text] [Related]
10. Emergence of a Novel Coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2: Biology and Therapeutic Options. Khan S; Siddique R; Shereen MA; Ali A; Liu J; Bai Q; Bashir N; Xue M J Clin Microbiol; 2020 Apr; 58(5):. PubMed ID: 32161092 [TBL] [Abstract][Full Text] [Related]
11. Natural Products Homoharringtonine and Emetine Alkaloids as SARS-CoV-2 Treatment Options. Sohrab SS; Suhail M; Kamal MA; Azhar EI Curr Pharm Des; 2021; 27(32):3444-3453. PubMed ID: 33302852 [TBL] [Abstract][Full Text] [Related]
12. A Photoactivable Natural Product with Broad Antiviral Activity against Enveloped Viruses, Including Highly Pathogenic Coronaviruses. Meunier T; Desmarets L; Bordage S; Bamba M; Hervouet K; Rouillé Y; François N; Decossas M; Sencio V; Trottein F; Tra Bi FH; Lambert O; Dubuisson J; Belouzard S; Sahpaz S; Séron K Antimicrob Agents Chemother; 2022 Feb; 66(2):e0158121. PubMed ID: 34807755 [TBL] [Abstract][Full Text] [Related]
13. Search, Identification, and Design of Effective Antiviral Drugs Against Pandemic Human Coronaviruses. Huang T; Sun L; Kang D; Poongavanam V; Liu X; Zhan P; Menéndez-Arias L Adv Exp Med Biol; 2021; 1322():219-260. PubMed ID: 34258743 [TBL] [Abstract][Full Text] [Related]
14. Surveillance of Bat Coronaviruses in Kenya Identifies Relatives of Human Coronaviruses NL63 and 229E and Their Recombination History. Tao Y; Shi M; Chommanard C; Queen K; Zhang J; Markotter W; Kuzmin IV; Holmes EC; Tong S J Virol; 2017 Mar; 91(5):. PubMed ID: 28077633 [TBL] [Abstract][Full Text] [Related]
15. Replication of Severe Acute Respiratory Syndrome Coronavirus 2 in Human Respiratory Epithelium. Milewska A; Kula-Pacurar A; Wadas J; Suder A; Szczepanski A; Dabrowska A; Owczarek K; Marcello A; Ochman M; Stacel T; Rajfur Z; Sanak M; Labaj P; Branicki W; Pyrc K J Virol; 2020 Jul; 94(15):. PubMed ID: 32434888 [TBL] [Abstract][Full Text] [Related]
16. Potent 3CLpro inhibitors effective against SARS-CoV-2 and MERS-CoV in animal models by therapeutic treatment. Li P; Kim Y; Dampalla CS; Nhat Nguyen H; Meyerholz DK; Johnson DK; Lovell S; Groutas WC; Perlman S; Chang K-O mBio; 2024 Feb; 15(2):e0287823. PubMed ID: 38126789 [TBL] [Abstract][Full Text] [Related]
17. From SARS coronavirus to novel animal and human coronaviruses. To KK; Hung IF; Chan JF; Yuen KY J Thorac Dis; 2013 Aug; 5 Suppl 2(Suppl 2):S103-8. PubMed ID: 23977429 [TBL] [Abstract][Full Text] [Related]
18. [Etiology of epidemic outbreaks COVID-19 on Wuhan, Hubei province, Chinese People Republic associated with 2019-nCoV (Nidovirales, Coronaviridae, Coronavirinae, Betacoronavirus, Subgenus Sarbecovirus): lessons of SARS-CoV outbreak.]. Lvov DK; Alkhovsky SV; Kolobukhina LV; Burtseva EI Vopr Virusol; 2020; 65(1):6-15. PubMed ID: 32496715 [TBL] [Abstract][Full Text] [Related]
19. COVID-19 in the Shadows of MERS-CoV in the Kingdom of Saudi Arabia. Barry M; Al Amri M; Memish ZA J Epidemiol Glob Health; 2020 Mar; 10(1):1-3. PubMed ID: 32175703 [TBL] [Abstract][Full Text] [Related]
20. Development of a Fluorescence-Based, High-Throughput SARS-CoV-2 3CL Froggatt HM; Heaton BE; Heaton NS J Virol; 2020 Oct; 94(22):. PubMed ID: 32843534 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]